| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.2 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |